Webinar: Palmar Foot Pain | Advances and Updates in Equine Podiatry
ArthramidVet hosted this discussion with Dr Andrew Watts and Dr Tracy Turner, experts in equine foot health. Our Panelists Dr Andrew Watts (AU): Graduating from University of Queensland in…
Contura Animal Health Holdings acquires Innovative Medical Solutions
Contura Vet Limited, a wholly owned subsidiary of Contura Animal Health Holdings Limited, (“Contura Vet”), the owner and distributor of ArthramidVet®, an innovative veterinary medical product used for the treatment…
Effective Arthritis Treatment: Summer’s Story
Summer, a 12-year-old pony, had a successful career as a Mini Prix show jumper and show hunter pony, winning many rugs and ribbons. However, over time, she began to experience…
Successful Treatment of a chronic tendon sheath injury with ArthramidVet® 2.5 iPAAG.
A Star Performer: 12-Year-Old Showjumping Crossbred Gelding In this case report we look at a 12-year-old crossbred gelding who show jumps competitively to 1.40m. Recently, the gelding developed acute tenosynovitis…
Case Report on a 9-year-old Warmblood mare, seasoned in Prix St. George dressage
Despite her talents the 9-year-old warmblood mare had difficulty in collecting behind, diminished power, and a reluctance to perform her best. No asymmetry was detected, so to uncover the root…
Dr Lisa Fortier Seminar | Intra-Articular Approaches to Osteoarthritis
ArthramidVet® and the NZVA offered an exclusive opportunity to hear from the esteemed Dr Lisa Fortier who, alongside Dr Jason Lowe, discussed Intra-Articular Approaches to Osteoarthritis, a general topic that…
ArthramidVet: getting Oscar back in the arena
Oscar, a KPWN Dutch Warmblood was bred and started in Europe, where he was internationally trained and competed up to Small Tour in UK and Netherlands. Oscar arrived in Australia…
Histologic and cytologic changes in normal equine joints after injection with 2.5% iPAAG hydrogel reveal low-level macrophage-driven foreign body response
The prestigious American Veterinary Medicine Association has published another 2.5% iPAAG (ArthramidVet®) study conducted by IMS Vet Directors Dr Jason Lowe and Dr Leigh de Clifford, in keeping with our…
ArthramidVet helping Rose go the distance
In the competitive world of endurance, maintaining peak performance is an endless challenge. In this blog post, we delve into the journey of Stonelea Sparking Rose (Rose), a 20-year-old part-bred…
What is a ‘joint-flare’ and can it happen with 2.5% iPAAG (ArthramidVet®)?
Intraarticular injections in horses are beneficial for managing various musculoskeletal conditions, but they do come with associated risks and should be performed by a suitably qualified and experienced veterinarian. Furthermore,…
New and Upcoming Advances in Equine Orthopedics
Updates on 2.5% iPAAG (Polyacrylamide Hydrogel) In our latest webinar, a number of expert practitioners discussed the latest findings of the use of 2.5% iPAAG (ArthramidVet) and upcoming advances. EquiManagement…
Recommendations and Safety of repeat dosing with 2.5% iPAAG ArthramidVet®
Introduction ArthramidVet® is a novel treatment and represents a paradigm shift in how veterinarians and owners think about treating lameness in horses. ArthramidVet® can be used in any joint that…
